Just before Passover, a final event of the second cycle of the PlayBeyondBio project in the field of digital health took place, which is jointly led by the British-Swedish pharma giant, Astraznica, the JVP venture capital fund, the international consulting giant Accenture, Margalit Startup City, Amazon Web Services and the Medical Center Justice in Jerusalem.
In the program's vision: Support for Israeli innovation in the field of digital health in order to address the significant challenges faced by the global health system, through the application of digital technologies and their access to the patient and the health system, in Israel and around the world.
The program focuses on promoting "digital health" in the practical and applied aspect by creating collaborations between startups and international pharma companies, investors, health institutions and international high-tech leaders.
Combining the strengths of a pharmaceutical company, a consulting and integration company, a venture capital fund, technology companies and hospitals together with startup companies have enabled the creation of a supportive shell that helps shatter the local glass ceiling and allows companies participating in the program to break into the global market.
The main support of the program is to identify the challenges that have been identified as most significant for Israeli startups, such as validating the solution with global customers, developing a sustainable business model, integrating solutions into healthcare systems outside Israel, using databases and thinking about ways to reach the market.
During the second cycle of the program, which lasted 6 months, 8 startups selected from 100 candidates participated.
The companies have partnered with global AstraZenica executives to implement their technologies jointly in Europe, the US, Canada and Israel, have been strategically accompanied by the product and market penetration by JVP, and have worked with Accenture and AWS to ensure their technological infrastructure is ready. - scale up on a global scale and in accordance with different health systems.
Erel Margalit, Founder and Chairman of JVP and Margalit Startup City: “The global healthcare system has changed, and it faces in the post-Corona era, new big challenges that require groundbreaking technological developments.
The world's big problem is becoming a huge opportunity for Israeli high-tech.
"Israel has a significant technological infrastructure and a broad ecosystem that enable it to become a world leader in digital health and bring to the world the next major initiatives that change the way medicine can be accessible to anyone, anywhere, anytime."
Ohad Goldberg, CEO of AstraZenica Israel: “AstraZenica is proud to be a leading company in the development of life-saving drugs for some of the most difficult and complicated diseases today.
It is important to us that Israel takes a significant part in the company's ability to bring to the market also advanced technological solutions that will be integrated into drug treatment and provide greater added value to patients, doctors and the health system.
In Israel, there are unique capabilities such as databases, advanced hospitals, AI development, etc. that can move this effort forward.
PlayBeyondBio's operations are part of a broader strategic vision and we are constantly exploring additional options for investing in the local ecosystem.
Astraznika sees the importance of investing in start-up companies in Israel and is proud to lead this venture.
Shimon Alkabetz, CEO of Accenture Israel: "The startups selected to take part in the program were accepted after a rigorous and thorough selection process that saw before its eyes the need for the hour and also the opportunities inherent in the field of medicine in the next decade.
As a company that proudly carries the banner of technological leadership and innovation around the world, we have no doubt that this leading team faithfully represents the best prominent trends in the worlds of mid-tech and wellness, including the implementation of artificial intelligence applications and advanced Big Data processing to streamline decision-making.
Accenture is proud to support these brilliant teams, connect them to the global network of our partners and clients and help accelerate and expand their solutions. "
Prof. Dan Turner, VP of R&D, Shaare Zedek Medical Center: "When it comes to developing technologies in digital health, medical data and biological samples are the infrastructure for new products. We at Shaare Zedek can not only provide information and samples safely, but also provide the Clinical knowledge to make this data relevant and meaningful for healthcare product development companies.In Shaare Zedek's giant servers, data from hundreds of thousands of medical files are documented each year, and our role in the technology development process is to promote access to medical staff data, samples and knowledge while fully maintaining "Privacy of personal information. We promote collaborations to test the products in a real clinical environment."
Were we wrong?
Fixed!
If you found an error in the article, we'll be happy for you to share it with us